Initiator Pharma A/S

CVR 37663808 · Public limited company (A/S) · Active · Low risk

Initiator Pharma A/S is a Public limited company (A/S), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 10 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 29.5m and a net result of DKK -13.7m. CEO: Claus Elsborg Olesen.

Bankruptcy risk for Initiator Pharma A/S

0.2%
probability of bankruptcy within 12 months
Low risk

0.2 × the average (1.41%) · higher risk than 49% of active Danish companies

Lowest riskHighest risk

Increases the risk

Return on assets< -20% · bankruptcy rate 16.7%1.9×
CEO's previous bankruptcies1 · bankruptcy rate 14.2%1.6×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Reporting classReporting class B · bankruptcy rate 3.2%0.37×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Company typeA/S · bankruptcy rate 4.4%0.50×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
37663808
Status
Active
Company type
Public limited company (A/S)
Founded
(10 years)
Address
Ole Maaløes Vej 3
2200 København N
Municipality
København
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 7.2m
Employees
1 (2018)
Auditor
Cedra Godkendt Revisionsaktieselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 10
Missing annual reportNo
Negative equityNo
Equity ratio87.5%
Current ratio1,635%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies1
Other companies at the address167
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK -14.8mDKK -11.1mDKK -23.4m
Net profitDKK -13.7mDKK -12.9mDKK -22.9m
EquityDKK 29.5mDKK 14.8mDKK 11.2m
Total assetsDKK 33.8mDKK 15.8mDKK 29.8m
CashDKK 26.2mDKK 13.4m–
Short-term debtDKK 2.1mDKK 1.1m–
Avg. employees12–

Latest annual report: Reporting class B · auditor's statement: Auditor's report on audited financial statements · DeloitteStatsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025161
1 Jan 2024 – 31 Dec 2024177
1 Jan 2023 – 31 Dec 2023164
1 Jan 2022 – 31 Dec 2022159
1 Jan 2021 – 31 Dec 2021160
1 Jan 2020 – 31 Dec 2020160
1 Jan 2019 – 31 Dec 2019152
1 Jan 2018 – 31 Dec 2018146
1 Jan 2017 – 31 Dec 2017155
2 May 2016 – 31 Dec 2016152

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOClaus Elsborg OlesenCurrent
BoardGunnar Magnus Severus Modée PerssonCurrent
BoardPeter Joakim HolmCurrent
BoardClaus Elsborg OlesenCurrent
BoardAnnette Ingegerd Marie ColinCurrent
BoardYlva Gunilla EkströmCurrent
BoardMajken Christina Östberg LloydCurrent
BoardClaus Elsborg Olesen
BoardUlf Simonsen
BoardDan Leif Peters
BoardHenrik Kristian Moltke
BoardGöran Albert Torstensson Ando
Owner (10%)Linc ABCurrent
Owner (5%)Adrigo Asset ManagementCurrent
Owner (10%)CLAUS OLESEN HOLDING ApS
Owner (10%)MIKAEL SØNDERGÅRD THOMSEN ApS
Owner (10%)Simonsen og Mogensen Holding ApS
Owner (10%)DanPET AB
Owner (50%)Saniona AB
Owner (5%)Jørgen Drejer
Owner (5%)Thomas Feldthus
Owner (5%)Jørgen Drejer
Owner (5%)Thomas Feldthus
Owner (5%)CLAUS OLESEN HOLDING ApS
Owner (5%)MIKAEL SØNDERGÅRD THOMSEN ApS
Owner (5%)Simonsen og Mogensen Holding ApS
Owner (5%)DanPET AB
AuditorCedra Godkendt RevisionsaktieselskabCurrent
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderCLAUS OLESEN HOLDING ApSCurrent
FounderSimonsen og Mogensen Holding ApSCurrent
FounderDanPET ABCurrent

The CEOs' other companies

Claus Elsborg Olesen – 10 other companies, of which 1 bankrupt

Address history (1 moves)

Ole Maaløes Vej 3, 2200 København N
c/o Claus Olesen Holding ApS, Lyngsiesvej 18, 8230 Åbyhøj

Employees per year

Number of employees at Initiator Pharma A/S per year112016: 020162017: 120172018: 12018

Other companies at the same address

Similar companies in København

Questions and answers about Initiator Pharma A/S

Has Initiator Pharma A/S gone bankrupt?

No, Initiator Pharma A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Initiator Pharma A/S?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.

Who is the CEO of Initiator Pharma A/S?

Claus Elsborg Olesen is the CEO of Initiator Pharma A/S.

Who is the auditor of Initiator Pharma A/S?

Initiator Pharma A/S most recently used Cedra Godkendt Revisionsaktieselskab.

When was Initiator Pharma A/S founded?

Initiator Pharma A/S was founded on 2 May 2016.

What is the equity of Initiator Pharma A/S?

Equity was DKK 29.5m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.